Hemogenyx Pharmaceuticals PLC announces Corporate Presentation
LONDON, UK / ACCESSWIRE / July 2, 2021 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical…
LONDON, UK / ACCESSWIRE / July 2, 2021 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical…
Strong Results of Mapping and Sampling Program To Guide Accelerated Exploration Plan for Smokey Lithium…
KUALA LUMPUR, MALAYSIA / ACCESSWIRE / July 2, 2021 / SEATech Ventures Corp. (OTC PINK:SEAV)…
Exercise of options and total voting rights GUILDFORD, UK / ACCESSWIRE / July 2, 2021…
Wieland expands its customer network in North America Acquisition is part of Wieland’s strategy to…
LONDON, UK / ACCESSWIRE / July 2, 2021 / Gabriel Resources Ltd. (TSXV trading symbol…
SYDNEY, AUSTRALIA / ACCESSWIRE / July 2, 2021 / NFT STARS. The new NFT marketplace…
JACKSONVILLE, FL / ACCESSWIRE / July 2, 2021 / Fuse Science, Inc.(OTC PINK:DROP), The company…
EASTLEIGH, UK / ACCESSWIRE / July 1, 2021 / i3 Energy plc (AIM:I3E)(TSX:ITE), an independent…
Telecoms and datacom marketplace Twoosk provides the top ten reasons to go virtual Aveiro, Portugal,…
HONG KONG and SHANGHAI, China and & FLORHAM PARK, N.J., July 02, 2021 (GLOBE NEWSWIRE)…
Philogen Announces R&D Program Update Fibromun shows activity in pretreated glioma and sarcoma patients; OncoFAP…
Press Release Nicox Announces Last Patient Completed NCX 4251 Mississippi Phase 2b Blepharitis Trial July…
Advicenne Receives MHRA Approval to Market Sibnayal™ (ADV7103) in the UK for the Treatment of…
-Data from PROLONG Phase 2a proof-of-concept study of ebopiprant (OBE022) for spontaneous preterm labor to be…
CAMBRIDGE, Mass., July 01, 2021 (GLOBE NEWSWIRE) — Cerevel Therapeutics (Nasdaq: CERE), a company dedicated…
SHANGHAI, China, July 02, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a…
HANGZHOU, China, July 02, 2021 (GLOBE NEWSWIRE) — Hangzhou Chance Pharmaceuticals (“Chance”), a clinical-stage biotechnology…
DUBLIN, Ireland and CHICAGO, July 01, 2021 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM)…
Management works to advance its BLA filing seeking FDA approval for leronlimab as a combination…